Kirsten E. Smith

Also affiliated with Johns Hopkins Medicine

Pharmacology, Toxicology and PharmaceuticsChemistryBiochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Kratom (Mitragyna speciosa): User demographics, use patterns, and implications for the opioid epidemic”.

Kratom (Mitragyna speciosa): User demographics, use patterns, and implications for the opioid epidemic

Drug and Alcohol Dependence(2020)10.1016/j.drugalcdep.2020.107849

N/A

0DataRank · unranked

179 citations

David J. Cox, Kirsten E. Smith, Kelly E. Dunn, Roland R. Griffiths, Albert Garcia‐Romeu

Characterization of diverted buprenorphine use among adults entering corrections-based drug treatment in Kentucky

Drug and Alcohol Dependence(2020)10.1016/j.drugalcdep.2020.107837

N/A

0DataRank · unranked

14 citations

Martha Tillson, Michele Staton, Erin Winston, Kirsten E. Smith

Risk factors for heroin use following release from jail or prison in adults in a Central Appalachian state between 2012-2017

The American Journal of Drug and Alcohol Abuse(2020)10.1080/00952990.2020.1725032

N/A

0DataRank · unranked

9 citations

Adrian J. Archuleta, Michele Staton, Erin Winston, Kirsten E. Smith

Kratom use in the United States: a diverse and complex profile

Addiction(2020)10.1111/add.15173

N/A

0DataRank · unranked

24 citations

Jane K. Babin, Jack E. Henningfield, Albert Garcia‐Romeu, Andrew C. Kruegel, Walter C. Prozialeck +4 more

When an obscurity becomes trend: social-media descriptions of tianeptine use and associated atypical drug use

The American Journal of Drug and Alcohol Abuse(2021)10.1080/00952990.2021.1904408

N/A

0DataRank · unranked

47 citations

Jeffrey M. Rogers, Justin C. Strickland, David H. Epstein, Kirsten E. Smith

Potential Value of the Insights and Lived Experiences of Addiction Researchers With Addiction

Journal of Addiction Medicine(2021)10.1097/adm.0000000000000867

N/A

0DataRank · unranked

31 citations

Kirsten E. Smith, Noel Vest, Devin P. Effinger, David H. Epstein, Samuel W. Stull

Associations of Lifetime Nonmedical Opioid, Methamphetamine, and Kratom Use within a Nationally Representative US Sample

Journal of Psychoactive Drugs(2021)10.1080/02791072.2021.2006374

N/A

0DataRank · unranked

17 citations

Jeffrey M. Rogers, Justin C. Strickland, Kirsten E. Smith

Kratom use as more than a “self-treatment”

The American Journal of Drug and Alcohol Abuse(2022)10.1080/00952990.2022.2083967

N/A

0DataRank · unranked

60 citations

Kelly E. Dunn, Jeffrey M. Rogers, Oliver Grundmann, Christopher R. McCurdy, Albert Garcia‐Romeu +4 more

Assessment of Kratom Use Disorder and Withdrawal Among an Online Convenience Sample of US Adults

Journal of Addiction Medicine(2022)10.1097/adm.0000000000000986

N/A

0DataRank · unranked

39 citations

Kelly E. Dunn, Jeffrey M. Rogers, Albert Garcia‐Romeu, Justin C. Strickland, David H. Epstein +1 more

How Essential is Kratom Availability and use during COVID-19? Use Pattern Analysis Based on Survey and Social Media Data

Substance Abuse(2022)10.1080/08897077.2021.2007517

N/A

0DataRank · unranked

19 citations

Charles A. Veltri, Diana Morcos, David Knightes, Kirsten E. Smith, Jeffrey M. Rogers +1 more

Examining the paradoxical effects of kratom: a narrative inquiry

Frontiers in Pharmacology(2023)10.3389/fphar.2023.1174139

N/A

0DataRank · unranked

32 citations

Jeffrey D. Feldman, Kelly E. Dunn, Christopher R. McCurdy, Stephanie T. Weiss, Oliver Grundmann +4 more

An update on the clinical pharmacology of kratom: uses, abuse potential, and future considerations

Expert Review of Clinical Pharmacology(2024)10.1080/17512433.2024.2305798

N/A

0DataRank · unranked

56 citations

Abhisheak Sharma, Kirsten E. Smith, Charles A. Veltri, Stephanie T. Weiss, C Michael White +2 more

Kratom addiction per DSM-5 SUD criteria, and kratom physical dependence: Insights from dosing amount versus frequency

Drug and Alcohol Dependence(2024)10.1016/j.drugalcdep.2024.111329

N/A

0DataRank · unranked

27 citations

Stephanie T. Weiss, David H. Epstein, Oliver Grundmann, Katherine Hill, Kirsten E. Smith +1 more

Controversies in Assessment, Diagnosis, and Treatment of Kratom Use Disorder

Current Psychiatry Reports(2024)10.1007/s11920-024-01524-1

N/A

0DataRank · unranked

17 citations

David H. Epstein, Stephanie T. Weiss, Kirsten E. Smith

Growing pains with kratom: experiences discussed in subreddits contrast with satisfaction expressed in surveys

Frontiers in Pharmacology(2024)10.3389/fphar.2024.1412397

N/A

0DataRank · unranked

16 citations

Kayla J. Colvin, David H. Epstein, Oliver Grundmann, Christopher R. McCurdy, Kirsten E. Smith +1 more

Chemical Analysis and Alkaloid Intake for Kratom Products Available in the United States

Drug Testing and Analysis(2025)10.1002/dta.3906

N/A

0DataRank · unranked

20 citations

Kirsten E. Smith, Michelle A. Kuntz, Erin C. Berthold, Omar I. Elashkar, Nicholas Guadagnoli +6 more

Is bedtime use of kratom (Mitragyna speciosa) a sleep aid or disruptor? Examining its daily effects and individual differences.

Experimental and Clinical Psychopharmacology(2025)10.1037/pha0000794

N/A

0DataRank · unranked

0 citations

Patricia Timmons, Leigh V. Panlilio, Christopher D. Verrico, Ynhi T. Thomas, C. Austin Zamarripa +3 more